Is ARK Genomic Revolution stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, ARK Genomic Revolution pays dividends. Last time was Friday 31st of December 2021 where the investors holding the stock on Wednesday 29th of December 2021 were paid $0.382 per share. Over the last 5 times between 2017 and 2021, ARK Genomic Revolution has paid $3.02 with an average of $0.6 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for ARK Genomic Revolution 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $29.98, you would have made a loss of $-5.74 per share or -19.15%
Yes, the average daily trading liquidity for ARK Genomic Revolution is $2.37 million. You should therefore be able to get in and out of your positions relatively fast.
ARK Genomic Revolution has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for ARK Genomic Revolution to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.